These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 33320478)

  • 1. [The place of sphingosine-1-phosphate modulators in the therapy of inflammatory bowel diseases].
    Szymaszkiewicz K; Szymaszkiewicz A; Fichna J
    Postepy Biochem; 2020 Mar; 66(1):42-48. PubMed ID: 33320478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of sphingosine-1-phosphate in inflammatory bowel disease.
    Peyrin-Biroulet L; Christopher R; Behan D; Lassen C
    Autoimmun Rev; 2017 May; 16(5):495-503. PubMed ID: 28279838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease.
    Verstockt B; Vetrano S; Salas A; Nayeri S; Duijvestein M; Vande Casteele N;
    Nat Rev Gastroenterol Hepatol; 2022 Jun; 19(6):351-366. PubMed ID: 35165437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unveiling the biological role of sphingosine-1-phosphate receptor modulators in inflammatory bowel diseases.
    Tourkochristou E; Mouzaki A; Triantos C
    World J Gastroenterol; 2023 Jan; 29(1):110-125. PubMed ID: 36683721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine-1-Phosphate Signaling in Inflammatory Bowel Disease.
    Nielsen OH; Li Y; Johansson-Lindbom B; Coskun M
    Trends Mol Med; 2017 Apr; 23(4):362-374. PubMed ID: 28283249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine-1-phosphate (S1P) signaling regulates the production of intestinal IgA and its potential role in the pathogenesis of canine inflammatory bowel disease.
    Nakazawa M; Maeda S; Yokoyama N; Nakagawa T; Yonezawa T; Ohno K; Matsuki N
    J Vet Med Sci; 2019 Sep; 81(9):1249-1258. PubMed ID: 31341112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine-1-Phosphate Signaling and Metabolism Gene Signature in Pediatric Inflammatory Bowel Disease: A Matched-case Control Pilot Study.
    Suh JH; Degagné É; Gleghorn EE; Setty M; Rodriguez A; Park KT; Verstraete SG; Heyman MB; Patel AS; Irek M; Gildengorin GL; Hubbard NE; Borowsky AD; Saba JD
    Inflamm Bowel Dis; 2018 May; 24(6):1321-1334. PubMed ID: 29788359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine-1-Phosphate Metabolism and Its Role in the Development of Inflammatory Bowel Disease.
    Wollny T; Wątek M; Durnaś B; Niemirowicz K; Piktel E; Żendzian-Piotrowska M; Góźdź S; Bucki R
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28362332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis.
    Pérez-Jeldres T; Alvarez-Lobos M; Rivera-Nieves J
    Drugs; 2021 Jun; 81(9):985-1002. PubMed ID: 33983615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingolipids as mediators of inflammation and novel therapeutic target in inflammatory bowel disease.
    Sukocheva OA; Lukina E; McGowan E; Bishayee A
    Adv Protein Chem Struct Biol; 2020; 120():123-158. PubMed ID: 32085881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine-1-Phosphate Lyase Inhibition Alters the S1P Gradient and Ameliorates Crohn's-Like Ileitis by Suppressing Thymocyte Maturation.
    Karuppuchamy T; Tyler CJ; Lundborg LR; Pérez-Jeldres T; Kimball AK; Clambey ET; Jedlicka P; Rivera-Nieves J
    Inflamm Bowel Dis; 2020 Jan; 26(2):216-228. PubMed ID: 31807751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis - a unique therapeutic target in inflammatory bowel disease.
    Wang J; Goren I; Yang B; Lin S; Li J; Elias M; Fiocchi C; Rieder F
    Aliment Pharmacol Ther; 2022 Feb; 55(3):277-291. PubMed ID: 34932238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of sphingosine-1-phosphate in ulcerative colitis.
    Argollo M; Furfaro F; Gilardi D; Roda G; Allocca M; Peyrin-Biroulet L; Danese S
    Expert Opin Biol Ther; 2020 Apr; 20(4):413-420. PubMed ID: 32093531
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration.
    Danese S; Furfaro F; Vetrano S
    J Crohns Colitis; 2018 Aug; 12(suppl_2):S678-S686. PubMed ID: 28961752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct roles for hematopoietic and extra-hematopoietic sphingosine kinase-1 in inflammatory bowel disease.
    Snider AJ; Ali WH; Sticca JA; Coant N; Ghaleb AM; Kawamori T; Yang VW; Hannun YA; Obeid LM
    PLoS One; 2014; 9(12):e113998. PubMed ID: 25460165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for therapeutic sphingolipids in inflammatory bowel disease?
    Parigi TL; Roda G; Argollo M; Gilardi D; Danese S
    Expert Rev Gastroenterol Hepatol; 2020 Jan; 14(1):47-54. PubMed ID: 31874053
    [No Abstract]   [Full Text] [Related]  

  • 17. Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease.
    Snider AJ; Wu BX; Jenkins RW; Sticca JA; Kawamori T; Hannun YA; Obeid LM
    Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):124-30. PubMed ID: 22940715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regulation of inflammatory bowel disease by amino acids].
    Sun Q; Wu H; Li S; Sun Z
    Sheng Wu Gong Cheng Xue Bao; 2022 Jun; 38(6):2128-2138. PubMed ID: 35786467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine 1-phosphate (S1P) receptor modulators as an induction and maintenance therapy for ulcerative colitis: a systematic review and meta-analysis of randomized controlled trials.
    Suilik HA; Jaber F; Abuelazm M; Ramadan A; Elzeftawy MA; Elrosasy A; Youssef RA; Abdelazeem B; Hashash JG; Farraye FA; Ghoz H
    Inflamm Res; 2024 Feb; 73(2):183-198. PubMed ID: 38153524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current therapeutic approaches in inflammatory bowel disease.
    Sohrabpour AA; Malekzadeh R; Keshavarzian A
    Curr Pharm Des; 2010; 16(33):3668-83. PubMed ID: 21128898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.